Brain Stem Gliomas Completed Phase 2 / 3 Trials for Bevacizumab (DB00112)

Also known as: Brain Stem Glioma / Brainstem Glioma / Glioma of brainstem

IndicationStatusPhase
DBCOND0087392 (Brain Stem Gliomas)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01236560Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade GliomaTreatment